At closing bell, the benchmark Hang Seng Index surged 2.31%, or 577.67 points, to 25,635.66. The Hang Seng China Enterprises Index added 1.46%, or 150.10 points, to 10,445.42.
Hong Kong equities kicked off the trading week on a positive note as vaccine hopes supported optimism. Pfizer and BioNTech reported early positive data on a joint coronavirus vaccine candidate. Another candidate from Oxford University and AstraZeneca also showed a positive immune response in an early trial. A team of scientists at Oxford University said their experimental coronavirus vaccine has been shown in an early trial to induce an immune response. The positive results of recent tests in the United States and Britain provided something for the market to look forward to, to help an economic recovery.
The coronavirus pandemic, which was first reported in China late last year, has infected more than 14.6 million people and killed over 608,000.
European leaders reached a breakthrough agreement over new fiscal stimulus, following marathon talks in Brussels over four days. The European Union's executive arm, the European Commission, will tap into financial markets to raise 750 billion euros ($857 billion), which would be distributed among countries and sectors most affected by the pandemic. The funds would be disbursed in the form of grants and loans.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
